New York Times Company (NYT)vsTNL Mediagene Ordinary Shares (TNMG)
NYT
New York Times Company
$85.17
+1.20%
COMMUNICATION SERVICES · Cap: $13.79B
TNMG
TNL Mediagene Ordinary Shares
$2.00
+1.88%
COMMUNICATION SERVICES · Cap: $81.09M
Smart Verdict
WallStSmart Research — data-driven comparison
New York Times Company generates 5533% more annual revenue ($2.80B vs $49.67M). NYT leads profitability with a 12.3% profit margin vs -1.7%. NYT earns a higher WallStSmart Score of 55/100 (C-).
NYT
Buy55
out of 100
Grade: C-
TNMG
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-114.5%
Fair Value
$33.27
Current Price
$85.17
$51.90 premium
Intrinsic value data unavailable for TNMG.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 20.8%
Reasonable price relative to book value
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -1.6% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : NYT
The strongest argument for NYT centers on Operating Margin. Revenue growth of 10.5% demonstrates continued momentum.
Bull Case : TNMG
The strongest argument for TNMG centers on Price/Book.
Bear Case : NYT
The primary concerns for NYT are Piotroski F-Score, PEG Ratio, P/E Ratio. A P/E of 40.8x leaves little room for execution misses.
Bear Case : TNMG
The primary concerns for TNMG are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
NYT profiles as a value stock while TNMG is a turnaround play — different risk/reward profiles.
TNMG carries more volatility with a beta of 1.24 — expect wider price swings.
NYT is growing revenue faster at 10.5% — sustainability is the question.
NYT generates stronger free cash flow (158M), providing more financial flexibility.
Bottom Line
NYT scores higher overall (55/100 vs 27/100) and 10.5% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
New York Times Company
COMMUNICATION SERVICES · PUBLISHING · USA
The New York Times Company provides news and information for readers and viewers on various platforms worldwide. The company is headquartered in New York, New York.
Visit Website →TNL Mediagene Ordinary Shares
COMMUNICATION SERVICES · PUBLISHING · USA
TNL Mediagene Ordinary Shares is a cutting-edge biopharmaceutical company dedicated to developing and commercializing innovative medical therapies aimed at addressing significant unmet health needs, with a focus on oncology and autoimmune disorders. By employing advanced technologies and fostering strong strategic partnerships, the company is strategically positioned for robust growth and long-term value creation. TNL Mediagene’s unwavering commitment to scientific innovation and research-driven approaches highlights its mission to improve patient outcomes and broaden the therapeutic landscape within the biopharmaceutical sector.
Visit Website →Compare with Other PUBLISHING Stocks
Want to dig deeper into these stocks?